ConductScience.org, home

Trial · NCT03135067

Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk

NCT03135067, Not applicable, Completed, University of Pennsylvania; results first posted 2022-12-16

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk. Trials, record NCT03135067. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03135067

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk
NCT number
NCT03135067
Status
Completed
Phases
Not applicable
Enrollment
2,102 participants, actual
Lead sponsor
University of Pennsylvania
Conditions
Human Immunodeficiency Virus
Interventions
Provision of multiple self-tests
First posted
2017-05-01
Last updated
2022-12-16
Results first posted
2022-12-16

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryHIV Incidence Per 100 Person Yearsup to 24 monthsHIV incidence over an average follow-up period of 18 months, and up to 24 months, per 100 person years
SecondaryIdentification of HIV-positive Male Partnersup to 24 months
Average number of sexual partners per participant that the participant reported as HIV positive over the course of the study (Total reported positive sexual partners divided by number of participants who completed at least one 6-month follow-up survey); the intent of this measure is to see if participants given HIV self-tests are more likely to identify HIV positive sexual partners.
SecondaryUsed Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positive
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Percentage of participants who used a condom with at least one sexual partner after partner refused self-test or HIV testing services referral card, or tested HIV-positive; Note that percentages are rounded to one decimal place.
SecondaryCouples Testing With Primary Partner
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Percentage of participants who report testing together with their primary partner; Note that percentages are rounded to one decimal place.
SecondaryPrimary Partner Tested for HIV
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Percentage of participants who report that their primary partner tested for HIV since enrollment; Note that percentages are rounded to one decimal place.
SecondaryDeclined Sex With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positive
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Percentage of participants who declined sex with at least one partner after partner refused self-test or HIV testing services referral card, or tested HIV-positive; Note that percentages are rounded to one decimal place.
OtherIntimate Partner Violence (IPV)
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Percentage of participants in each study group who experience IPV; Note that percentages are rounded to one decimal place.

Outcomes7

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYHIV Incidence Per 100 Person Yearsup to 24 monthscases per 100 person yearsNUMBER
SECONDARYIdentification of HIV-positive Male Partnersup to 24 monthspartners per participantsMEAN
SECONDARYUsed Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positive
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Secondary outcomes were assessed at 6, 12, 18, and 24 month surveys. HIV testing (primary outcome) also occurred at 9, 15, and 21 months, so the number of overall participants may not match what is reported for the primary outcome.
percentage of participantsNUMBER
SECONDARYCouples Testing With Primary Partner
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Secondary outcomes were assessed at 6, 12, 18, and 24 month surveys. HIV testing (primary outcome) also occurred at 9, 15, and 21 months, so the number of overall participants may not match what is reported for the primary outcome.
percentage of participantsNUMBER
SECONDARYPrimary Partner Tested for HIV
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Secondary outcomes were assessed at 6, 12, 18, and 24 month surveys. HIV testing (primary outcome) also occurred at 9, 15, and 21 months, so the number of overall participants may not match what is reported for the primary outcome.
percentage of participantsNUMBER
SECONDARYDeclined Sex With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positive
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Secondary outcomes were assessed at 6, 12, 18, and 24 month surveys. HIV testing (primary outcome) also occurred at 9, 15, and 21 months, so the number of overall participants may not match what is reported for the primary outcome.
percentage of participantsNUMBER
OTHER_PRE_SPECIFIEDIntimate Partner Violence (IPV)
Data was measured longitudinally up to 24 months for some subjects; all participants were measured through 18 months. Measures reported are from 18 month follow-up for behavior occurring in the past 6 months.
Secondary outcomes were assessed at 6, 12, 18, and 24 month surveys. HIV testing (primary outcome) also occurred at 9, 15, and 21 months, so the number of overall participants may not match what is reported for the primary outcome.
percentage of participantsNUMBER

Results by group44

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
HIV Incidence Per 100 Person YearsProvision of Multiple Self-tests1.18cases per 100 person years
HIV Incidence Per 100 Person YearsReferral Vouchers for VCT.98cases per 100 person years
Identification of HIV-positive Male PartnersProvision of Multiple Self-tests.26Standard Deviation 0.71partners per participants
Identification of HIV-positive Male PartnersReferral Vouchers for VCT.13Standard Deviation 0.48partners per participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveProvision of Multiple Self-tests6 months11.6percentage of participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveReferral Vouchers for VCT6 months6.2percentage of participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveProvision of Multiple Self-tests12 months7.2percentage of participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveReferral Vouchers for VCT12 months5.2percentage of participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveProvision of Multiple Self-tests18 months5.3percentage of participants
Used Condom With at Least One Partner After Partner Refused Self-test or HIV Testing Services Referral Card, or Tested HIV-positiveReferral Vouchers for VCT18 months4.3percentage of participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDProvision of Multiple Self-tests1,06333
Overall StudySTARTEDReferral Vouchers for VCT1,03933
Overall StudyCOMPLETEDProvision of Multiple Self-tests1,01933
Overall StudyCOMPLETEDReferral Vouchers for VCT99133
Overall StudyNOT COMPLETEDProvision of Multiple Self-tests440
Overall StudyNOT COMPLETEDReferral Vouchers for VCT480

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherIntimate partner violence and social harmsSocial circumstancesProvision of Multiple Self-tests2411,017
otherIntimate partner violence and social harmsSocial circumstancesReferral Vouchers for VCT210985

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityProvision of Multiple Self-tests11,019
Total, all-cause mortalityReferral Vouchers for VCT1991
Total, other adverse eventsProvision of Multiple Self-tests2411,017
Total, other adverse eventsReferral Vouchers for VCT210985
Total, serious adverse eventsProvision of Multiple Self-tests01,019
Total, serious adverse eventsReferral Vouchers for VCT0991

Papers37

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
12172528BACKGROUNDPubMed
15060443BACKGROUNDPubMed
17554213BACKGROUNDPubMed
18664301BACKGROUNDPubMed
19372521BACKGROUNDPubMed
21575149BACKGROUNDPubMed
21990966BACKGROUNDPubMed
22293029BACKGROUNDPubMed
22424777BACKGROUNDPubMed
22893194BACKGROUNDPubMed

1 to 10 of 37

See all 37 papers

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01MH111602Secondary distribution of HIV self-tests: an innovative strategy for promoting male partner testing and reducing riskTHIRUMURTHY, HARSHAUNIVERSITY OF PENNSYLVANIANATIONAL INSTITUTE OF MENTAL HEALTH2016 to 2020

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Provision of Multiple Self-tests vs Referral Vouchers for VCT: deaths from any causeTrial comparisons
Provision of Multiple Self-tests vs Referral Vouchers for VCT: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03135067

GET https://conductscience.org/api/trials/v1/NCT03135067/results?page=2